4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Cash generated from core business operations
Latest
$-109.08M
↓ 72% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-63.43M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-109.08M | +18.9% |
| 2024 | $-134.59M | -77.6% |
| 2023 | $-75.79M | +12.6% |
| 2022 | $-86.69M | -25.4% |
| 2021 | $-69.13M | -35.8% |
| 2020 | $-50.91M | -38.7% |
| 2019 | $-36.71M | -125.9% |
| 2018 | $-16.25M | -297.3% |
| 2017 | $8.24M | - |